Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
Product revenues $ 1,892,638 $ 1,066,551 $ 3,814,853 $ 2,432,705
Other revenues 83,367 37,330 168,224 65,311
Total revenues 1,976,005 1,103,881 3,983,077 2,498,016
Cost of product revenues 798,498 520,987 1,550,962 1,217,533
Research and development costs 1,084,202 749,942 1,641,901 1,407,134
Selling, general, and administrative expenses 1,915,601 1,888,056 3,966,130 3,862,305
Operating loss (1,822,296) (2,055,104) (3,175,916) (3,988,956)
Other income (expense):        
Gain (loss) from change in fair value of derivative liabilities 31,307 263,927 (61,739) 424,045
Gain from debt restructuring 121,224 121,224
Other income (expense), net (715) 139,239 3,412 214,380
Interest expense, net (212,709) (251,250) (425,908) (596,475)
Net loss $ (2,004,413) $ (1,781,964) $ (3,660,151) $ (3,825,782)
Net loss per share attributable to common stockholders:        
Basic and diluted (in dollars per share) $ (0.32) $ (0.9) $ (0.74) $ (1.66)
Weighted average shares outstanding:        
Basic and diluted (in shares) 6,315,759 1,971,071 4,976,337 2,309,537